Professional Documents
Culture Documents
BCG X B Capital DHP VF Compressed
BCG X B Capital DHP VF Compressed
Revolutionizing Healthcare
OCTOBER 2023
The move towards higher spend per capita on respiratory diseases etc.) growing at 9% overtook practitioners and specialists will remain a
healthcare has emerged as a key barometer the acute disease burden in 2014. In this context, constrained resource in India for the foreseeable
of economic development and growth. This and with a growing middle class and awareness future (0.7 physicians per ‘000 people compared to
demonstrates the importance of healthcare of health, as well as increasing government WHO standard of 1). Given that these shortcomings
from a government policy perspective, as well expenditure on health (from 1.4% in 2018 to 2.2% will not be overcome in a short period of time,
as the increasing prioritization of healthcare by in 2022), we expect the overall healthcare market to leveraging technology remains the one viable way
individuals and corporates. In India, this curve has grow from $167Bn in 2022 to $458Bn in 2030. to circumvent the country’s lack of physical care
been moving upwards in recent years, driven by a infrastructure at scale. Driven by COVID, rapid
confluence of forces, from a per capita healthcare With a growing spend, Indian healthcare still digitization, increasing penetration of smartphones
spend of $45 in 2014 to $68 in 2021. However, it suffers from the classical challenges which is called and the internet, the pace of digital innovation in
very much lags the healthcare spend compared to the Iron-Triangle in healthcare – challenges of Indian healthcare is accelerating and an increasing
other large economies – thus reflecting the gap access, affordability, and quality. The healthcare number of founders are creating innovative
and potential in the sector. infrastructure in India is well below WHO platforms focused on these specific patient and
standards (1.2 beds per ‘000 people compared to doctor needs. Global and local investors have
India suffers from ‘dual disease’ burden with the WHO standard of 5). Inspite of investments helped support this trend with record levels of
acute disease burden growing at 6%, while chronic in recent years in increasing medical colleges funding since 2021.
disease burden (diabetes, cardiac diseases, and institutions, skilled professionals – general
The government, too, has taken a series of journey. It offers a fantastic opportunity for digital- opportunities, especially at the early stage, while
progressive steps and initiatives, such as the bold native founders and incumbents to reimagine how providing an insight into where the challenges lie.
and ambitious Ayushman Bharat Digital Mission healthcare will be delivered in the future. We can These trends around technology-led innovation are
that aims to create a unified digital healthcare stack expect a transformation in how patients will seek what we envision will become the digital pill for
to promote digital health and improve healthcare and receive care. We expect a trajectory change revolutionizing healthcare in India.
outcomes. In particular, the mission aims to in how doctors and healthcare providers will seek
create a secure exchange of medical data between to give acute and chronic care. We also expect
different stakeholders in the healthcare ecosystem. the payers – i.e., health insurance companies to
Such a platform will help expand the reach of integrate into this ecosystem to create efficiency
digital health solutions while ensuring better and better patient outcomes. While it is difficult
clinical outcomes for patients across India's diverse to crystal ball gaze, our estimates suggest that
population segments. the digital health market in India can grow 10x
from $2.7Bn in 2022 to ~$37Bn by 2030. In this
Driven by the above factors, the evolution of digital report, we have outlined key drivers that will
healthcare in India is at a critical point in its lead to continued innovation and investment
01 02 03
Introduction
Healthcare delivery ripe for disruption in India
Healthcare Healthcare
2022 2030
3% Healthcare spending % of GDP 6% Healthcare spending % of GDP
~55% of Healthcare spend that is OOP ~36% of Healthcare spend that is OOP
India lags major economies in overall healthcare Government healthcare spending in India on the rise
spending as % of GDP with aim to increase spend to 2.5% of GDP by 2025
Current Health Expenditure as a % of GDP1 India Government Health Expenditure (INR Lakh Crore)
19% 5.5
5.2
13%
12%
10% 3.2
2.7 2.7
6%
3%
India China Brazil UK Germany USA 2018 2019 2020 2021 2022
As a %
of GDP 1.4 1.4 1.6 2.2 2.2
1. Data as of 2020
Source: World Health Organization; Global Health Expenditure Database; CRISIL Research; CEIC Data
11.6
Despite COVID-19 related
10.0 hospital admissions going
9.6 down in the recent past,
8.7 medical inflation in India
8.1 has continued to rise.
— Business Today
Chronic diseases, such as cardio and diabetes comprise India now has the 2nd largest diabetes population,
the major disease burden in India most of them are not treated
Breakdown of Disease Breakdown of NCD Disease Type 2 Diabetes3 Prevalence (Mn Patients) –
Burden in India (%) Burden in India (%) Top 3 Countries
141
Cardiac 24%
Number of Beds per 1,000 People Number of Physicians per 1,000 People Number of Nurses & Midwives per 1,000 People
15.7
-70%
5
4.3
2.6 -4%
2.9 2 2.7
-30% 2.5
2.4
1.2 1
0.7
India WHO China USA India WHO China USA India WHO China USA
Healthcare
Market Entity Providers Pharmacy Diagnostics Lab Insurance1
Key Complexities
in the Indian Inadequate Fragmented Inadequate infrastructure
Healthcare Market Limited awareness
infrastructure supply chain in Tier 2 cities
Emerging from the Where's the Value? Show Me Omnichannel and Specialty and
Hype Cycle… the Money! Omnipresent Preventive Care
Bigger and Better
Broader adoption of Sizable value pools being Funding environment Service expansion into Increasing specialty care
digital healthcare disrupted by healthtech remains robust with adjacencies and solutions customized for
has flourished broader archetypes of vertically-integrated the Indian environment
post the pandemic business models delivery being driven by
being financed underlying unit economics
01 02 03 04 05
New asset light Rising insurance Incumbents are ramping Greater collaboration Consolidation being led
providers are emerging penetration and OPD up digital presence and between incumbents by several deep pocketed
and gaining traction coverage to drive greater competitive intensity and digital natives players. Category
adoption of online specialists likely to
consultations continue to succeed
& patient services
06 07 08 09 10
Internet & smartphone adoption Preference for online consultations in the future
780
3% 6%
Number of Indian 343 11%
Internet Users (Mn) 29% 29%
2016 2022
Percentage of Percentage of
Patients (%) Patients (%)
2x
49% 36%
600 37%
2016 2022 Definitely prefer May prefer Will prefer only if offline isn't there Will not prefer
Source: Indus Valley; India Times; Live Mint; BCG Survey 2020 (conducted in June 2020 covering 400 respondents); BCG Analysis
Usage of digital health platforms continues to grow Key factors leading to rise in usage of digital
post the pandemic healthcare adoption
Average Monthly Active Users [MAU] (Mn)
12
Pandemic-Induced Adoption
People unable to access physical outlets,
10 doctors or pharma stores offline due to
lockdown and contagion constraints
6
4
3
3
2 3 Retention Led by Price & Convenience
2
1 Users found digital platforms cheaper while
offering a wider range of options, higher
service quality and greater convenience vs.
MediBuddy Practo HealthifyMe PharmEasy physical counterparts
Tata 1mg
2019 2022
COVID contact tracing, self-assessment and National telemedicine program to provide Bringing existing healthcare ecosystem
real-time advisories to citizens primary care to remote areas online via unique digital IDs and digitizing
all parts of the value chain
Easy vaccine administration - find vaccine Health insurance scheme to provide free 380Mn+ 20Mn+ 1.7Mn+
centers, book slots & receive digital certificates secondary & tertiary care for EWS
Implemented in Phase 1
1. Personalized Health ID 2. Standardized Healthcare Provider Registry 3. Longitudinal Patient Health Records
• Enables interoperability & sharing of data across • Enables higher quality of care & tracking of • Allows for longitudinal care & predictive solutions
providers and platforms outcomes over time • Patient to be sole owner of his/her data;
• Drives accountability across healthcare consent-enabled sharing
professionals and providers
4. Coverage and Claims Platform 5. Open Telemedicine and E-Pharmacy Network 6. Health Data Analytics
• Enables OPD insurance, reduced cost of claims • Promotes open-source models allowing inter- • Enables creation of better disease control
and higher genuineness operability and choice to users programs
• Faster and cheaper settlements for insurers would • Private players invited to build own platform • Creates new opportunities for research and
further reduce cost of insurance for customers clinical advancements
~$35Bn Digital Heath India Market Size 2030E ($Bn) Driven by 6 Major Trends
Total Digital Health 2.7 1-2% 37 7-8% Rising Digital Consumerism: ~46% smartphone
users consuming digital solutions
12-
E-Pharmacy 3-5% 15% Increasing Power of Payer: Up to ~10% digital
distribution by traditional insurers
12 30-
1.1 3-5% 35%
E-Diagnostics
New Ecosystems: With digital natives &
incumbents creating newer solutions
1-2% 3-5%
Teleconsultation 10
0.5
Beyond the Pill: Play by pharma companies
<0.5% 3 3-5% via digital disease management
Surgery Aggregation 0.4
5 12-
0.2 3-5% 15% Connected Devices: 100Mn+ wearables
Healthcare Financing shipped to India in 2022
0.3 5
<1% 3-5%
0.2 3 NDHM: Significant push to operationalize
Fitness & Specialty Care
Market Size ($Bn) % Penetration Market Size ($Bn) % Penetration
digital backbone across India
2022 2030
Sources: Jefferies, RedSeer, UBS Equities, Expert Interviews, Annual Reports, BCG Analysis
01
Broad Teleconsult
Ecosystem Play
Marketplace Practo MediBuddy Visit Health
Distribution Play
Plum Onsurity
04
Health
Financing Full Stack Model
Digit Kenko
05 Health SaaS Innovaccer Triomics Eluciddata Arintra Cloudphysician Carpl Redbrik AI CoverSelf
Phase 01 Phase 02
2.5
India Healthtech VC Funding ($Bn)
Series C+
Series B/C
1.0 1.1
Series A 0.6
0.4 0.4
Seed
Tapped into base layer of supply (pharmacies, gyms etc.) while Higher awareness post Covid-19 leading to rise of health insurance
improving delivery experience for end users distribution models and full stack plays with OPD coverage
1. 2022 till Dec-22
Source: Tracxn
Fitness & Wellness $1Bn+ 1 1 • Rise in fitness consciousness; wearables seeing adoption
Healthcare Financing $0.1Bn+ 0 0 • Point-of-sale financing and OPD insurance emerging areas
Digital Players Partnering with Insurance Provider-focused Expanding to Group Health Hospital Tie-ups
Plays Corporates Distribution +
B2B Focus & Bancassurance Pristyn Care
Partnerships
MediBuddy Tata 1mg Eka Care Visit Health Kenko Plum Hexa Health Ayu Health
Tele Surgery
Metric Unit E-Pharmacy E-Diagnostic1 Consultation2 Specialty Care Aggregation
We decided to start
online-to-offline model
where online would
GM % 25-30% 60-80% 10-30% 50-80% 20-30%
focus on attracting
new customers and
offline would service
orders and build
CAC INR 1-1.4K ~2.5K 0.7-1.2K 1-7K 10-15K customer loyalty.
— Co-Founder,
A Large Marketplace
Company
1. Blended economics for marketplace and captive model 2. Captive Models generally have Fixed Rate Consultation Fees Whereas Marketplace Models Generally Pass Consultation Fees to Patient and Charge a Commission
3. Higher AOV where wearables plays involved
Source: Management Information; Expert Interviews; B Capital Group Analysis; BCG Analysis
Advertisements
Marketplace2
consultation1
Distribution
E-Pharmacy
Diagnostics
Offline B2B
Pharmacies
Label Play
Solutions
Private
Offline
SAAS
B2B
Tele
In the USA, small
3P
verticals have very high
MedPlus 4-5 value pools so niche
businesses can be
sustainable whereas in
Apollo Pharmacy 2-3
India, cost structures
are too high to justify
Flipkart Health+ 4-5 the ROI in individual
value pools.
NetMeds 16-19
Owning multiple product
and service ecosystems
Tata 1mg 30-32
is critical to improve
margin structures.
PharmEasy 40-42
— Co-Founder,
Leading E-Pharmacy Player
% Market Digital Plays Supply Side Plays
Share
1. Does not include consultations for prescription validation 2. Includes Retailio 1P and 3P GMV
Source: Target Data; Investor Presentations; Medplus DRHP; Expert Discussions; BCG Analysis
Store-in-store Model with Potential to Support Online Channel Progress of E-Pharmacy players
Online is still <5% of market so it is imperative to move offline to capture acute Rx demand, better service patients looking for immediate
fulfillment and build strong customer loyalty.
— Co-Founder, Leading E-Pharmacy Player
Gross
25-30% 30-35% 40-50%
Margin
Scale
$50Mn $50–200Mn $200Mn+
Required
Most E-Pharma players surpassing PharmEasy seeing highest industry Private label contribution still nascent
Example scale required to negotiate Gross Margin (~31%) through building (~1-2% for pure online players, 5-8% for
better margins large B2B network for direct purchase offline retailers going online)
Significant expansion in diagnostic presence through … driven by 15-20% higher CM realization with supply
own labs… chain ownership and higher quality control
No. of owned labs (FY 22) Metric Unit Marketplace Labs Own Labs
COGS % - 30%
Newer teleconsultation players like Eka Care are adopting a B2B-focused GTM approach
30L+ App Downloads 7L+ Monthly Active Users 50L+ Vitals Stored 10L+ Rx Generated
Region
Preventing Care
• Information provider
• Personal health management
• Community/social care
Finding Care
• Symptom checking
• Registration service
• Appointment booking
Receiving Care
•
•
Telemedicine service
Diagnostic services
Platforms started from
telehealth offering
Continuing Care but evolved to offer
• At-home care delivery
• E-Pharmacy comprehensive solutions
• Disease mgmt. & monitor. across the patient journey
Paying for Care
• Insurance coverage
• Insurance products sales
Enabling the Journey
• IT software as a service
• Data analysis (decision support, PHM)
• El. Health Records (EHR)
• Health Information System (HIS)
Focused on patients who need diabetes, cancer, Critical/chronic health issues require
Patients specialized care plans
cardio, dental or PCOS/sexual wellness care
Acquisition Online | Omnichannel Primary acquisition online via performance Offline channel improving patient
Channel marketing; players gradually expanding offline reach at lower CAC
Range of pricing plans with varying
Range of Care 3 Months | 6 Months | Annual Affordable monthly or annual subscription plans value prop. - allows users to choose
Packages with emphasis on delivering end outcomes plans as per needs and reduce
friction to adoption
• No solution for daily • Calorie-tracking tailored • Simple yet frequent use- 3.0Mn
2012-2015 calorie and nutrition for Indian food case drove engagement 2016
tracking & retention 1.8Mn
We are doing full stack of health and wellness offerings. We started out as calorie tracker and are now Total Installed Base
expanding up the value chain to provide AI-based assistance and real coaches
Monthly Active Users
- Founder, A digital health & wellness Co
Diabetic patients in India typically find it hard to BeatO partnered with Care Insurance, to
buy health insurance with adequate protection offer insurance along with a comprehensive
increase in average weekly
wellness offering 3x monitoring frequency
India has consistently struggled with maintaining Smaller hospitals are facing even significantly lower
hospital occupancy levels compared to peers occupancy compared to larger chains
64% 60-70%
25-30%
Pristyn Care | Hexa Health | MedFin As India experiences larger heterogeneity in care and
15-30% inequitable distribution of care expertise in centers, we
Aggregator Insurance claim support and
post-surgery follow-up care wanted to build integrated tech platforms for India context
— Co-founder, Surgery Care Aggregator
AOV Pay-Outs Net Take Rate
Moving from individual tie ups with diagnostic centres and small labs to becoming a demand aggregator across
multiple platforms to capture greater market share
Started by providing pay-per-use remote tele-radiology Expanding services to digital demand aggregation
services for offline centers and fulfillment model
INR 3-4K INR 3-4K
Patients Patients
Source: Expert Interview; Lit Research; BCG Analysis AOV Pay-Outs Net Take Rate
Insurance coverage to improve from 37% today to …with increasing shift in mix towards insured coverage
69% by 2030… vs. OOP spends
% of lives covered by insurance in India OOP as a % of current health expenditure
35
46
55
69
55
65
37 54
45
Outpatient Coverage Expected to Clock ~2x YoY Growth… …Driven by 4 Major Trends
Key
Players Kenko Clinikk Visit Health Star Health Insurance ICICI Lombard HDFC ERGO People have realized that
conventional insurance
remains under-utilized in
• Started with OPD benefits as differentiator • Traditionally focused on surgery and accidental the long run as it doesn't
Core • Introducing new features such as “no cap coverage include OPD. Almost 70%
Offering on room rent” and “additional sum insured” • Adding standalone OPD benefits or bundled with of lifetime healthcare
across all policies IPD for the corporate segment expenses incurred are
on OPD costs and it
• Enhancing hospital coverage esp. in Tier 2+ • Large hospital coverage across India is necessary to bridge
Network • Suite of digital healthtech services • Limited digital healthtech services covered; this gap by providing
& Benefits e.g., free teleconsult, expanding offline services leveraging partnership with digital players complete financing as
well as assistance.
• Affordable monthly/annual subscription plan • Annual plans with add-ons for any additional service — Co-Founder,
Pricing • Customized pricing with AI/ML model-based OPD Benefits Player
underwriting using health data points
• Digital & user-friendly onboarding & claim • Transitioning from paper-based to digital system
User
Experience management process for onboarding & claims management
• Easy to read policy and simple terms
and conditions
Building OPD services and D2C Ramping up offline-to-online Building digital patient support Setting up digital platforms to
channels and VAHS products to presence and fulfillment services programs and platforms to enable online bookings and
compete with digital attackers to improve value capture improve patient adherence improve customer experience
Institutional play is becoming large with insurance taking center stage on digital capabilities and specialty pharma ramping up their D2C
programs to meet patient demands.
— Co-Founder, Leading Digital Health Player
Traditional insurers are investing heavily in digital and building OPD services to improve
consumer value proposition
• Digital enhancement of selfservice • AI for instant claim approval, • AI-based chatbots and self-service
Digital channels, telemedicine centers chatbots etc. and specialized channels and digital customer
etc. and conversational AI and digital arm to build new digital engagement and rewards program
Initiatives
image recognition products for startups (i.e. Vault)
• Standalone Outpatient Care • Rider OPD policy (i.e. BeFit) covering • Rider OPD policy on traditional
OPD Insurance Policy launched physio, teleconsultations through health insurance products
Offerings covering Rx, Dx, physio, non- ICICI Lombard TakeCare app etc. especially for senior citizens
allopathic treatment etc. prone to frequent health issues
Larger providers are significantly investing in tech and leveraging existing infrastructure to
improve reach and value creation
Apollo’s Distinctive Digital Ecosystem Enabled by its Formidable
Impact Realized
Physical Network and Capabilities
or
Patient
n
Delivery
23Mn+
Cli
m
Co
es
Registrations Cumulative Registrations
5Mn+ lives
4K+ Apollo Consumer covered through
Pharmacy Apollo Munich
Stores 0.7Mn+
Active Users Daily Active Users
300+
10K+ Apollo Corporate
Doctors Tie-ups Well-being 6.3K+
30Mn+
0.5K+ 3Mn+ IPD/OPD Companion Providers Onboarded
Apollo Annual visits till
Physical Diagnostic chronic date
Centers
Network & patients
Future Launch…
Capabilities Health Insurance, Condition Management,
Well-being Companion
Leading domestic pharma players are instituting digital patient support programs to drive
engagement and adherence
• Provides a digital therapeutics • Gamified health-related incentives, • Improves patient adherence through
platform linking cardiologists, coaches, tailored guidance for patients a network of certified educators and
Competitive and care managers to patients and and scientific information, virtual medication reminder features and
Advantage personalized risk management learning tools, patient progress enhances patient experience through
services for heart health review for doctors real-time query resolution via a live
chat portal
Area of
• Cardiology • Thyroid, Diabetes, Osteoarthritis • Respiratory
Focus
Online test booking for sample home collection Online test booking for free sample home WhatsApp and app based test booking and
through mobile app including test suggestions collection through mobile app including live customer chat support along with free home
based on inputs and online report downloads and chatbot support and easy access to all trend collection of sample and Apollo Life collaboration
ongoing health monitoring analyses and download of reports with Jiyo on digital wellness platform (health
tracking, well-being tips) for corporates
Source: Respective company websites, HBS, IIFL Securities report April 2021, Economic Times, Expert interviews
Startups Incumbents
Use Cases
Developing Symptoms |
Staying Healthy Obtaining Treatment Recovering | Post Care
Getting Sick
• Personalized health • AI-based timely diagnosis • Make educated decisions: • Continuous monitoring
coaching engine Access to range of hospitals,
• Doctor recommendations • On-demand medication and
doctors
• Incentives to keep healthy – home nursing service Partner ecosystem
• Medicine delivery
premium discounts, products • Cashless payments is critical for
• Access to quick & convenient driving growth
• Cloud for report storage • Instant claim process/Straight
advice e.g. tele/video calling while maintain cost
through processing
structures. We have
Insurer becomes control centre: Gatekeeps members access to solutions, introduced new
collects data along the way, can use data for predictive analysis verticals through
partnerships to
Examples of Partnerships tap into growth
opportunities.
Star Health Insurance Star Health Insurance Aditya Birla Health Care Health Insurance
— Senior Leader, A
GOQii Tata 1mg MobiKwik BeatO Large Marketplace
Company
Aditya Birla Health Niva Bupa Health Insurance Care Health Insurance
Abbott | GOQii |
Dr. Reddy's | ICICI Lombard Cipla | GoApptiv
HealthifyMe | Fitterfly
• DRL’s subsidiary Svaas is launching • Abbott has partnered with multiple • Cipla acquired 22% stake in GoApptiv,
Description cashless digital outpatient ecosystem DTx platforms for their continuous a platform to engage channel
in partnership with ICICI Lombard glucose monitoring (CGM) device partners digitally
Freestyle Libre
Area of • Multi-service cashless outpatient • Chronic therapy (diabetes) • End-to-end brand marketing
Focus services across specializations and channel engagement
delivered via application across 2-6 tier towns
• Bringing together 4 key touchpoints in • Improve patient outcomes by • Enabling wider patient reach with
Benefits the outpatient journey-consultations, developing a connected healthcare affordable and quality drugs
diagnostic services, pharmacies & ecosystem for holistic diabetes
insurance management
• Platform is allowing patients to monitor symptoms (based on ePRO) and offering cognitive
Roche/Genentech Flood Light Open CNS (Multiple Sclerosis) activities to improve patient QoL
• Ongoing registry study aims to enroll 10K MS patients
• Weight management and education platform to improve lives of people living with obesity
Novo Nordisk Noom Obesity • "Novo Nordisk patients using Saxenda gained significant value from the combined offering
of SaxendaCare & Noom" – Camilla Sylvest, Novo EVP of Commercial Strategy
Source: Otsuka US Press Release; Gene.com; Onduo.com; The Aesthetic Society (Surgery.org); Biospace.com
Market Share of Top 3 Pharmacies Market Share of Top 3 Distributors Market Share of Top 3 Laboratories
38%
10%
5%
2% 3%
Source: EIU; WHO; World Bank; National Statistics Agencies; BCG Analysis
E-pharmacy will be a
30% Medlife multi-player game (5-6 at
PharmEasy 42% the least) due to need for
localized networks and
(Merged in 2015)
PharmEasy omnichannel. It will be
25% hard for a single player
to be omnipresent given
fragmented nature of
Tata 1mg TATA Digital 31% pharmacy and diagnostic
(Acquired By)
18% laboratory market.
12% — Co-Founder,
NetMeds Reliance 20%
(Acquired By) Leading E-pharmacy Player
15% 4%
Others Flipkart 3%
(SastaSundar Acquired By)
2019 2022
Despite the presence of horizontal e-commerce players, Healthtech is a well-suited market for deep play
category specialists have emerged as winners by vertical players
Grocery Retail
Supply-Side Drivers
D-Mart Reliance Fresh
• Storage and delivery of pharma products requires
deep operational expertise – especially in
m/s ↣ ~30% ~10%
temperature-controlled supply chains
• Reverse logistics operations in pharma are
complex as products are to be returned
Music Streaming to the manufacturer
Gaana JioSaavn
India India
Goods China USA Brazil UK Germany (current) (expected)
Consumer
Electronics
Consumer
Durables
Books
Personal and
Home Care
Grocery
Apparel and
Footwear
Digital Health
Products
Sources: BCG Analysis Dominant Horizontal Play Dominant Vertical Play Mixed Play
Type of Service
Pharmacy
Consultation Selection of
Diagnostic Scope of Services
Procedures
Wellness & Specialty Care
Financing
Service Delivery
Online Selection of Service
Delivery Mode
Omnichannel
Vertically Integrated
01 02 03 04 05
Clearly identify Sharply define your Identify tipping points Reimagine go-to-market 'Move Fast and
value pools to 'right to win' beyond and step changers in unit by exploring partnerships Break Things' approach
target as healthcare customer acquisition and economics in a clear-eyed and ecosystems to may not necessarily
spend pools increasingly experience. Define scope manner to drive business augment service delivery be applicable as
diversify beyond of services (horizontal model construct and go- capabilities keeping healthcare is a
consumer out-of-pocket vs. focused) and mode to-market approach patient centricity, multi-stakeholder
to insurance and spend of delivery (online vs. core capabilities, and system; Factor in business
mix changes from omnichannel) based service build and model how different
inpatient to outpatient on customer needs and delivery costs into stakeholders influence
organizational capabilities consideration the patient journey and
sources of funds
01 02 03 04 05
Integrate digital into Recognize that winning in Clearly define role Identify and monitor Reimagine go-to-
DNA as consumer trends digital requires different of digital in overall key flex points in unit market by developing
and digital adoption strategic, organizational, strategy as economics as per the partnerships and
are changing irreversibly and operational 1. Standalone digital defined role of digital in ecosystems with
and digital adoption so far capabilities and services are targeting overall strategy to drive digital natives to
has been led by natives; approach from winning in new customers sustainable adoption and augment service delivery
as natives develop physical; develop 2. Increase cross-sell growth of digital capabilities in core and
omnichannel capabilities, digital capabilities and in existing customer emerging businesses
incumbents need to approach with a ground base to boost core
develop and execute on up 'start-up' mindset business
a comprehensive digital 3. Enable a process step
strategy change in service
delivery in existing
service lines
BCG
Priyanka Aggarwal Kshitij Vijayvargiya Shaleen Sinha Nikhil Chari Neil Pinto Ketan Kapuria
Managing Director & Senior Partner Managing Director & Partner Managing Director Partner Consultant Senior Knowledge Analyst
Boston Consulting Group Boston Consulting Group Boston Consulting Group Boston Consulting Group Boston Consulting Group Boston Consulting Group
B Capital Group
If you would like to discuss the themes and content of this report, please contact: This report is a joint initiative between the
Boston Consulting Group (BCG) and the
B Capital Group.
Priyanka Aggarwal Nikhil Chari Karan Mohla
Managing Director and Partner, General Partner, We thank all the participants for their valuable
Senior Partner, BCG Mumbai B Capital Group contributions through the 1-on-1 discussions
BCG Singapore Chari.Nikhil@bcg.com karan@bcapgroup.com we have had towards the enrichment of
Aggarwal.Priyanka@bcg.com the report.
Neil Pinto Deepanshu Pattanayak
Kshitij Vijayvargiya Consultant, Senior Associate, Marketing Process: India Marketing team
Managing Director BCG Mumbai B Capital Group
and Partner, Pinto.Neil@bcg.com dpattanayak@bcapgroup.com Design & Production: Jamshed Daruwalla,
BCG New Delhi Rahul Surve, Saroj Singh, Pradeep Hire, Sujatha
Vijayvargiya.Kshitij@bcg.com Ketan Kapuria Chandan Deep Moraes, Abbasali Asamdi, Saurabh Tikekar,
Senior Knowledge Analyst, VP, Strategy and Operations, Dillibabu Muthu, and Saanchi Chatwal.
Shaleen Sinha BCG New Delhi B Capital Group
Managing Director Kapuria.Ketan@bcg.com cdeep@bcapgroup.com
BCG Bengaluru
Sinha.Shaleen@bcg.com Mehul Garg
Associate, Strategy and
Operations,
B Capital Group
mgarg@bcapgroup.com
© The Boston Consulting Group, Inc. 2023. All regard to the document. Receipt and review of this sources. BCG has not independently verified the
Rights Reserved. document shall be deemed agreement with and data and assumptions from these sources used in
consideration for the foregoing. these analyses. Changes in the underlying data or
This document has been prepared in good faith operating assumptions will clearly impact the
on the basis of information available at the This document is based on a primary qualitative analyses and conclusions.
date of publication without any independent and quantitative research executed by BCG.
verification. BCG does not guarantee or make any BCG does not provide legal, accounting, or tax This document is not intended to make or
representation or warranty as to the accuracy, advice. Parties are responsible for obtaining influence any recommendation and should
reliability, completeness, or currency of the independent advice concerning these matters. not be construed as such by the reader or
information in this document nor its usefulness This advice may affect the guidance in the any other entity.
in achieving any purpose. Readers are responsible document. Further, BCG has made no undertaking
for assessing the relevance and accuracy of the to update the document after the date hereof, This document does not purport to represent
content of this document. It is unreasonable for notwithstanding that such information may the views of the companies mentioned in the
any party to rely on this document for any purpose become outdated or inaccurate. BCG does not document. Reference herein to any specific
and BCG will not be liable for any loss, damage, provide fairness opinions or valuations of market commercial product, process, or service by trade
cost, or expense incurred or arising by reason transactions, and this document should not name, trademark, manufacturer, or otherwise,
of any person using or relying on information in be relied on or construed as such. Further, any does not necessarily constitute or imply its
this document. To the fullest extent permitted by evaluations, projected market information, and endorsement, recommendation, or
law (and except to the extent otherwise agreed conclusions contained in this document are based favoring by BCG.
in a signed writing by BCG), BCG shall have no upon standard valuation methodologies, are not
liability whatsoever to any party, and any person definitive forecasts, and are not guaranteed by Apart from any use as permitted under the US
using this document hereby waives any rights and BCG. BCG has used data from various sources Copyright Act 1975, no part may be reproduced
claims it may have at any time against BCG with and assumptions provided to BCG from other in any form.